Cargando…

In Silico Analysis Predicts a Limited Impact of SARS-CoV-2 Variants on CD8 T Cell Recognition

Since the start of the COVID-19 pandemic, mutations have led to the emergence of new SARS-CoV-2 variants, and some of these have become prominent or dominant variants of concern. This natural course of development can have an impact on how protective the previously naturally or vaccine induced immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isaeva, Olga I., Ketelaars, Steven L. C., Kvistborg, Pia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094405/ https://www.ncbi.nlm.nih.gov/pubmed/35572563 http://dx.doi.org/10.3389/fimmu.2022.891524

Ejemplares similares

Identification and characterization of a SARS-CoV-2 specific CD8(+) T cell response with immunodominant features
por: Gangaev, Anastasia, et al.
Publicado: (2021)

CD8(+) T-cell immune escape by SARS-CoV-2 variants of concern
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
por: Melo-González, Felipe, et al.
Publicado: (2021)

Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
por: Aparicio, Belén, et al.
Publicado: (2023)

CD8(+) T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives
por: Mortezaee, Keywan, et al.
Publicado: (2022)

Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
por: Aparicio, Belén, et al.
Publicado: (2023)

Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination
por: Nogimori, Takuto, et al.
Publicado: (2023)

Impaired Priming of SARS-CoV-2-Specific Naive CD8(+) T Cells in Older Subjects
por: Gallerani, Eleonora, et al.
Publicado: (2021)

LBA73 The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLA-A*01:01
por: Kvistborg, P., et al.
Publicado: (2020)

Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein
por: Visvabharathy, Lavanya, et al.
Publicado: (2023)

Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell immunoprofiling
por: Schreibing, Felix, et al.
Publicado: (2022)

Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8(+)T cells
por: Lie-Andersen, Olivia, et al.
Publicado: (2023)

Integrin Activation Enables Sensitive Detection of Functional CD4(+) and CD8(+) T Cells: Application to Characterize SARS-CoV-2 Immunity
por: Schöllhorn, Anna, et al.
Publicado: (2021)

Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm
por: Boni, Carolina, et al.
Publicado: (2021)

Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains
por: Lee, Chloe H., et al.
Publicado: (2020)

From Infection to Immunity: Understanding the Response to SARS-CoV2 Through In-Silico Modeling
por: Castiglione, Filippo, et al.
Publicado: (2021)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Omicron variants of SARS-CoV-2 and long COVID
por: Yang, Chengliang, et al.
Publicado: (2022)

Defining the pediatric response to SARS-CoV-2 variants
por: Ho, Reanne M., et al.
Publicado: (2023)

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
por: Favorskaya, Irina A., et al.
Publicado: (2022)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Impaired CD4(+) T cell recognition of SARS-CoV-2 variants of concern
Publicado: (2022)

Dominant CD8(+) T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination
por: Taus, Ellie, et al.
Publicado: (2022)

Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice
por: Fisher, Eva, et al.
Publicado: (2021)

SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron
por: Mazzoni, Alessio, et al.
Publicado: (2022)

In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein
por: Das, Nabarun Chandra, et al.
Publicado: (2022)

Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an In Silico Proteomics Approach
por: Kesarwani, Veerbhan, et al.
Publicado: (2021)

The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom
por: Wu, Jiajing, et al.
Publicado: (2021)

SARS-CoV-2’s Variants of Concern: A Brief Characterization
por: Scovino, Aline Miranda, et al.
Publicado: (2022)

Role of COVID-19 Vaccines in SARS-CoV-2 Variants
por: Zhou, Zhou, et al.
Publicado: (2022)

Editorial: SARS-CoV-2 variants, B lymphocytes, and autoreactivity
por: Radic, Marko Z., et al.
Publicado: (2023)

SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response
por: Turner, Jackson S., et al.
Publicado: (2021)

Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8(+) T cells
por: Lopes-Ribeiro, Ágata, et al.
Publicado: (2023)

Cross-reactive humoral and CD4(+) T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population
por: Martel, Fabiola, et al.
Publicado: (2023)

Combination of In Silico Methods in the Search for Potential CD4(+) and CD8(+) T Cell Epitopes in the Proteome of Leishmania braziliensis
por: e Silva, Rafael de Freitas, et al.
Publicado: (2016)

Structural Basis for SARS-CoV-2 Nucleocapsid Protein Recognition by Single-Domain Antibodies
por: Ye, Qiaozhen, et al.
Publicado: (2021)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants
por: Isaacs, Ariel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_po62svvnt3lkg4ojtqrc14pm8i